Clazuril

This classification denotes an antiparasitic agent with the molecular formula C17H10Cl2N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O8W0R05772, chemically known as benzeneacetonitrile, 2-chloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3h)-yl)- but generally known as clazuril, which bears US NIH Compound Identifier 58901. European Medicines Agency schedules Clazuril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06645MIG. The term CLAZURIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). CLAZURIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clazuril under HS 29336980 and SITC 51576. As of Q4 2014, CLAZURIL remains the US FDA Preferred Term for this commodity. Clazuril bears US NLM identifiers UMLS ID C0055867 and NCI Concept Code C82246. SMILES: CLC1C(C(C2CCC(CL)CC2)C#N)CCC(N2NCC(=O)[NH]C2=O)C1.